scholarly journals Understanding Alcohol Expectancy Effects: Revisiting the Placebo Condition

2006 ◽  
Vol 30 (2) ◽  
pp. 339-348 ◽  
Author(s):  
Maria Testa ◽  
Mark T. Fillmore ◽  
Jeanette Norris ◽  
Antonia Abbey ◽  
John J. Curtin ◽  
...  
2020 ◽  
Vol 34 (2) ◽  
pp. 327-334 ◽  
Author(s):  
Christine M. Lee ◽  
Anne M. Fairlie ◽  
Jason J. Ramirez ◽  
Megan E. Patrick ◽  
Jeremy W. Luk ◽  
...  

2021 ◽  
Author(s):  
Jacob Aday ◽  
Boris D. Heifets ◽  
Steven D. Pratscher ◽  
Ellen Bradley ◽  
Raymond Rosen ◽  
...  

Rationale: Psychedelic research continues to garner significant public and scientific interest with a growing number of clinical studies examining a wide range of conditions and disorders. However, expectancy effects and effective condition masking have been raised as critical limitations to the interpretability of the research.Objective: In this article, we review the many methodological challenges of conducting psychedelic clinical trials and provide recommendations for improving the rigor of future research.Results: We found that although some challenges are shared with psychotherapy and pharmacology trials more broadly, psychedelic clinical trials have to contend with several unique sources of potential bias. The subjective effects of a high-dose psychedelic are often so pronounced that it is difficult to mask participants to their treatment condition; the significant hype from positive media coverage on the clinical potential of psychedelics influences participants’ expectations for treatment benefit; and participant unmasking and treatment expectations can interact in such a way that makes psychedelic therapy highly susceptible to large placebo and nocebo effects. Specific recommendations to increase the success of masking procedures and reduce the influence of participant expectancies concern study development, participant recruitment and selection, incomplete disclosure of the study design, choice of active placebo condition, as well as the measurement of participant expectations and masking efficacy.Conclusion: Incorporating these design elements is intended to reduce the risk of bias in psychedelic clinical trials and thereby increase the ability to discern treatment-specific effects of psychedelic therapy


Author(s):  
Michiel van Elk ◽  
George Fejer ◽  
Pascal Lempe ◽  
Luisa Prochazckova ◽  
Martin Kuchar ◽  
...  

AbstractThere is an increased societal trend to engage in microdosing, in which small sub-hallucinogenic amounts of psychedelics are consumed on a regular basis. Following subjective reports that microdosing enhances the experience of nature and art, in the present study we set out to study the effects of psilocybin microdosing on feelings of awe and art perception. In this preregistered combined field- and lab-based study, participants took part in a microdosing workshop after which they volunteered to self-administer a psilocybin microdose or a placebo for three consecutive weeks, while the condition was kept blind to the participants and researchers. Following a 2-week break, the condition assignment was reversed. During each block, participants visited the lab twice to measure the effects of psilocybin microdosing vs. placebo. We used standardized measures of awe, in which participants reported their experiences in response to short videos or when viewing abstract artworks from different painters. Our confirmatory analyses showed that participants felt more awe in response to videos representing funny animals and moving objects in the microdosing compared to the placebo condition. However, about two-third of our participants were breaking blind to their experimental condition. Our exploratory findings suggest that expectancy-effects may be a driving factor underlying the subjective benefits of microdosing.


2010 ◽  
Vol 58 (5) ◽  
pp. 481-489 ◽  
Author(s):  
Kelly Cue Davis ◽  
Jeanette Norris ◽  
Danielle M. Hessler ◽  
Tina Zawacki ◽  
Diane M. Morrison ◽  
...  

2002 ◽  
Vol 23 (2) ◽  
pp. 205-216 ◽  
Author(s):  
Ralf Demmel ◽  
Jutta Hagen

Zusammenfassung: Gegenstand der vorliegenden Arbeit ist die Entwicklung eines ökonomischen Verfahrens zur Erfassung von Alkoholwirkungserwartungen. An einer Stichprobe von insgesamt 714 Erwachsenen - bzw. verschiedenen Teilstichproben - wurden erstmals Faktorenstruktur, psychometrische Eigenschaften und Validität einer deutschsprachigen Version des Alcohol Expectancy Questionnaire (AEQ) überprüft. Die Faktorenstruktur der deutschsprachigen Version entspricht nicht der des amerikanischen Originalinstruments. Eine zweifaktorielle Lösung lässt sich in Übereinstimmung mit den Annahmen psychologischer Modelle der Genese von Alkoholabhängigkeit und -missbrauch interpretieren: Faktor 1 (Erleichterung des Sozialkontakts) beschreibt eine Zunahme sozialer Kompetenz, Faktor 2 (Spannungsreduktion und Affektregulation) die Erwartung intrapsychischer Effekte. Zusammenhänge zwischen Konsummaßen und den AEQ-Summenwerten lassen sich als erste Hinweise auf die Validität des Verfahrens interpretieren.


1998 ◽  
Author(s):  
Jeannette M. Johansson ◽  
Evan R. Harrington
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document